Exousia Pro, Inc. (MAJI)

OTCMKTS · Delayed Price · Currency is USD
0.0285
+0.0013 (4.78%)
Mar 9, 2026, 12:57 PM EST
14.00%
Market Cap 1.20M
Revenue (ttm) -12.83K
Net Income (ttm) -661.35K
Shares Out 44.05M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,868
Average Volume 301,523
Open 0.0260
Previous Close 0.0272
Day's Range 0.0260 - 0.0313
52-Week Range 0.0150 - 0.3199
Beta -4.80
RSI 41.70
Earnings Date Jun 18, 2026

About Exousia Pro

Exousia Pro, Inc., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Marijuana, Inc. and changed its name to Exousia Pro, Inc. in April 2025. Exousia Pro, Inc. was incorporated in 2010 and is based in Saint Petersburg, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol MAJI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.